Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy
Gwyn Bebb, Colum Smith, Stewart Rorke, William Boland, Leonardo Nicacio, Ryan Sukhoo, Anthony BradeVolume:
67
Language:
english
Pages:
9
DOI:
10.1007/s00280-010-1379-9
Date:
April, 2011
File:
PDF, 422 KB
english, 2011